Growth Metrics

Barinthus Biotherapeutics (BRNS) Shares Outstanding (2020 - 2025)

Historic Shares Outstanding for Barinthus Biotherapeutics (BRNS) over the last 6 years, with Q3 2025 value amounting to $40.8 million.

  • Barinthus Biotherapeutics' Shares Outstanding rose 324.9% to $40.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.8 million, marking a year-over-year increase of 324.9%. This contributed to the annual value of $40.2 million for FY2024, which is 411.74% up from last year.
  • As of Q3 2025, Barinthus Biotherapeutics' Shares Outstanding stood at $40.8 million, which was up 324.9% from $40.3 million recorded in Q2 2025.
  • Barinthus Biotherapeutics' Shares Outstanding's 5-year high stood at $40.8 million during Q3 2025, with a 5-year trough of $8.2 million in Q1 2021.
  • Over the past 5 years, Barinthus Biotherapeutics' median Shares Outstanding value was $38.5 million (recorded in 2023), while the average stood at $36.7 million.
  • Its Shares Outstanding has fluctuated over the past 5 years, first soared by 36716.82% in 2021, then surged by 133.05% in 2022.
  • Quarter analysis of 5 years shows Barinthus Biotherapeutics' Shares Outstanding stood at $37.2 million in 2021, then grew by 1.33% to $37.7 million in 2022, then rose by 2.55% to $38.6 million in 2023, then grew by 4.12% to $40.2 million in 2024, then increased by 1.47% to $40.8 million in 2025.
  • Its Shares Outstanding stands at $40.8 million for Q3 2025, versus $40.3 million for Q2 2025 and $40.3 million for Q1 2025.